Detalhe da pesquisa
1.
Characterization of liposomal carriers for the trans-scleral transport of Ranibizumab.
Sci Rep
; 7(1): 16803, 2017 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29196745
2.
Drug, delivery and devices for diabetic retinopathy (3Ds in DR).
Expert Opin Drug Deliv
; 13(11): 1625-1637, 2016 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-27169870
3.
Folate targeting of drug carriers: a mathematical model.
J Control Release
; 104(1): 113-28, 2005 May 05.
Artigo
Inglês
| MEDLINE | ID: mdl-15866339
4.
Controlled targeting of liposomal doxorubicin via the folate receptor in vitro.
J Control Release
; 92(1-2): 49-67, 2003 Sep 19.
Artigo
Inglês
| MEDLINE | ID: mdl-14499185
5.
Sustained-release from nanocarriers: a review.
J Control Release
; 193: 122-38, 2014 Nov 10.
Artigo
Inglês
| MEDLINE | ID: mdl-24862321
6.
Sustained drug release in nanomedicine: a long-acting nanocarrier-based formulation for glaucoma.
ACS Nano
; 8(1): 419-29, 2014 Jan 28.
Artigo
Inglês
| MEDLINE | ID: mdl-24392729
7.
Nanomedicine for glaucoma: sustained release latanoprost offers a new therapeutic option with substantial benefits over eyedrops.
Drug Deliv Transl Res
; 4(4): 303-9, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25787063
8.
Nanomedicine for glaucoma: liposomes provide sustained release of latanoprost in the eye.
Int J Nanomedicine
; 7: 123-31, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22275828
9.
Sustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eye.
PLoS One
; 6(9): e24513, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-21931735
10.
Polymer- and liposome-based nanoparticles in targeted drug delivery.
Front Biosci (Schol Ed)
; 2(3): 801-14, 2010 06 01.
Artigo
Inglês
| MEDLINE | ID: mdl-20515826